β-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis

Gastroenterology

Volumn 148, Issue 7, 2015, Pages 1294-1310

  Monga, Satdarshan Pal ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

E Cadherin; HCC; Liver Fibrosis; Liver Tumors; NASH; WNT; Catenin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AXIN; AXIN1 PROTEIN; AXIN2 PROTEIN; BETA CATENIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CTNNB1 PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME P450 2E1; FORKHEAD BOX PROTEIN O; FORKHEAD TRANSCRIPTION FACTOR; FRIZZLED PROTEIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 49; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; NECDIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TCF4 PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; UNINDEXED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; WNT5A PROTEIN; XENOBIOTIC AGENT;

CELL ACTIVATION; CELL NUCLEUS; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE METABOLISM; HEPATOBLASTOMA; HEPATOCELLULAR ADENOMA; HOMEOSTASIS; HUMAN; LIPOGENESIS; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FOCAL NODULAR HYPERPLASIA; LIVER INJURY; LIVER LOBULE; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; MYOFIBROBLAST; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRIENT; OXIDATION REDUCTION STATE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SOMATIC MUTATION; STELLATE CELL; WNT SIGNALING PATHWAY; ANIMAL; CELL TRANSFORMATION; LIVER; LIVER DISEASE; LIVER TUMOR; METABOLISM; PATHOLOGY;

ANIMALS; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84930031124     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.02.056     Document Type: Review

References (169)

1. C.M. Cruciat, and C. Niehrs Secreted and transmembrane wnt inhibitors and activators Cold Spring Harb Perspect Biol 5 2013 a015081
2. J. Behrens, B.A. Jerchow, and M. Wurtele Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta Science 280 1998 596 599
3. C. Liu, Y. Li, and M. Semenov Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 108 2002 837 847
4. S. Amit, A. Hatzubai, and Y. Birman Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway Genes Dev 16 2002 1066 1076
5. H. Aberle, A. Bauer, and J. Stappert Beta-catenin is a target for the ubiquitin-proteasome pathway EMBO J 16 1997 3797 3804
6. I.S. Winer, G.T. Bommer, and N. Gonik Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation J Biol Chem 281 2006 26181 26187
7. J.J. Barrott, G.M. Cash, and A.P. Smith Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome Proc Natl Acad Sci U S A 108 2011 12752 12757
8. C. Banziger, D. Soldini, and C. Schutt Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells Cell 125 2006 509 522
9. K. Bartscherer, N. Pelte, and D. Ingelfinger Secretion of Wnt ligands requires Evi, a conserved transmembrane protein Cell 125 2006 523 533
10. A.J. Mikels, and R. Nusse Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context PLoS Biol 4 2006 e115
11. K.A. Knudsen, A.P. Soler, and K.R. Johnson Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin J Cell Biol 130 1995 67 77
12. J.E. Nieset, A.R. Redfield, and F. Jin Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin J Cell Sci 110 1997 1013 1022
13. M.J. Wheelock, and K.A. Knudsen Cadherins and associated proteins In Vivo 5 1991 505 513
14. A.H. Huber, and W.I. Weis The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin Cell 105 2001 391 402
15. T.S. Jou, D.B. Stewart, and J. Stappert Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex Proc Natl Acad Sci U S A 92 1995 5067 5071
16. M. Ozawa, and R. Kemler Altered cell adhesion activity by pervanadate due to the dissociation of alpha-catenin from the E-cadherin.catenin complex J Biol Chem 273 1998 6166 6170
17. S. Roura, S. Miravet, and J. Piedra Regulation of E-cadherin/catenin association by tyrosine phosphorylation J Biol Chem 274 1999 36734 36740
18. P. Hu, E.J. O'Keefe, and D.S. Rubenstein Tyrosine phosphorylation of human keratinocyte beta-catenin and plakoglobin reversibly regulates their binding to E-cadherin and alpha-catenin J Invest Dermatol 117 2001 1059 1067
19. J. Piedra, D. Martinez, and J. Castano Regulation of beta-catenin structure and activity by tyrosine phosphorylation J Biol Chem 276 2001 20436 20443
20. R. Rosato, J.M. Veltmaat, and J. Groffen Involvement of the tyrosine kinase fer in cell adhesion Mol Cell Biol 18 1998 5762 5770
21. J. Behrens, L. Vakaet, and R. Friis Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene J Cell Biol 120 1993 757 766
22. H. Hoschuetzky, H. Aberle, and R. Kemler Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor J Cell Biol 127 1994 1375 1380
23. Y. Kanai, A. Ochiai, and T. Shibata c-erbB-2 gene product directly associates with beta-catenin and plakoglobin Biochem Biophys Res Commun 208 1995 1067 1072
24. K. Takahashi, K. Suzuki, and Y. Tsukatani Induction of tyrosine phosphorylation and association of beta-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence Oncogene 15 1997 71 78
25. P. Bonvini, W.G. An, and A. Rosolen Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription Cancer Res 61 2001 1671 1677
26. S.P. Monga, W.M. Mars, and P. Pediaditakis Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes Cancer Res 62 2002 2064 2071
27. S. Shibamoto, M. Hayakawa, and K. Takeuchi Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells Cell Adhes Commun 1 1994 295 305
28. G. Zeng, U. Apte, and A. Micsenyi Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions Exp Cell Res 312 2006 3620 3630
29. U. Apte, G. Zeng, and P. Muller Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice Hepatology 44 2006 992 1002
30. R. Purcell, M. Childs, and R. Maibach HGF/c-Met related activation of beta-catenin in hepatoblastoma J Exp Clin Cancer Res 30 2011 96
31. B. Cieply, G. Zeng, and T. Proverbs-Singh Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene Hepatology 49 2009 821 831
32. M. Nishita, M.K. Hashimoto, and S. Ogata Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer Nature 403 2000 781 785
33. Y. Hoshida, S.M. Nijman, and M. Kobayashi Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res 69 2009 7385 7392
34. T. Sekiya, S. Adachi, and K. Kohu Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells J Biol Chem 279 2004 6840 6846
35. K. Nejak-Bowen, A. Kikuchi, and S.P. Monga Beta-catenin-NF-kappaB interactions in murine hepatocytes: a complex to die for Hepatology 57 2013 763 774
36. Q. Du, X. Zhang, and J. Cardinal Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells Cancer Res 69 2009 3764 3771
37. S. Hino, C. Tanji, and K.I. Nakayama Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination Mol Cell Biol 25 2005 9063 9072
38. S. Taurin, N. Sandbo, and Y. Qin Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase J Biol Chem 281 2006 9971 9976
39. W. Goessling, T.E. North, and S. Loewer Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration Cell 136 2009 1136 1147
40. M. Fanti, S. Singh, and G.M. Ledda-Columbano Tri-iodothyronine induces hepatocyte proliferation by protein kinase A-dependent beta-catenin activation in rodents Hepatology 59 2014 2309 2320
41. C. Spirli, L. Locatelli, and C.M. Morell Protein kinase A-dependent pSer(675) -beta-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis Hepatology 58 2013 1713 1723
42. J. Riese, X. Yu, and A. Munnerlyn LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic Cell 88 1997 777 787
43. M. Brannon, M. Gomperts, and L. Sumoy A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus Genes Dev 11 1997 2359 2370
44. R. Stadeli, R. Hoffmans, and K. Basler Transcription under the control of nuclear Arm/beta-catenin Curr Biol 16 2006 R378 R385
45. A. Kaidi, A.C. Williams, and C. Paraskeva Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia Nat Cell Biol 9 2007 210 217
46. N. Lehwald, G.Z. Tao, and K.Y. Jang Wnt-beta-catenin signaling protects against hepatic ischemia and reperfusion injury in mice Gastroenterology 141 2011 707 718 718 e1-5
47. H. Choi, Y.S. Chun, and T.Y. Kim HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin Cancer Res 70 2010 10101 10111
48. M.A. Essers, L.M. de Vries-Smits, and N. Barker Functional interaction between beta-catenin and FOXO in oxidative stress signaling Science 308 2005 1181 1184
49. D. Hoogeboom, M.A. Essers, and P.E. Polderman Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity J Biol Chem 283 2008 9224 9230
50. H. Liu, M.M. Fergusson, and J.J. Wu Wnt signaling regulates hepatic metabolism Sci Signal 4 2011 ra6
51. S. Benhamouche, T. Decaens, and C. Godard Apc tumor suppressor gene is the "zonation-keeper" of mouse liver Dev Cell 10 2006 759 770
52. S. Sekine, B.Y. Lan, and M. Bedolli Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice Hepatology 43 2006 817 825
53. X. Tan, J. Behari, and B. Cieply Conditional deletion of beta-catenin reveals its role in liver growth and regeneration Gastroenterology 131 2006 1561 1572
54. J. Yang, L.E. Mowry, and K.N. Nejak-Bowen Beta-catenin signaling in murine liver zonation and regeneration: a Wnt-Wnt situation! Hepatology 60 2014 964 976
55. S.P. Monga Role and regulation of beta-catenin signaling during physiological liver growth Gene Expr 16 2014 51 62
56. R. Gebhardt, and A. Hovhannisyan Organ patterning in the adult stage: the role of Wnt/beta-catenin signaling in liver zonation and beyond Dev Dyn 239 2010 45 55
57. M. Colletti, C. Cicchini, and A. Conigliaro Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation Gastroenterology 137 2009 660 672
58. A. Gougelet, C. Torre, and P. Veber T-cell factor 4 and beta-catenin chromatin occupancies pattern zonal liver metabolism in mice Hepatology 59 2014 2344 2357
59. S.F. Grant, G. Thorleifsson, and I. Reynisdottir Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes Nat Genet 38 2006 320 323
60. W. Ip, W. Shao, and Y.T. Chiang The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis Am J Physiol Endocrinol Metab 303 2012 E1166 E1176
61. W. Liu, R. Singh, and C.S. Choi Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure J Biol Chem 287 2012 7213 7223
62. N.A. Shackel, P.H. McGuinness, and C.A. Abbott Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression Gut 49 2001 565 576
63. A. Tanaka, P.S. Leung, and T.P. Kenny Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis J Autoimmun 17 2001 89 98
64. M. Chilosi, V. Poletti, and A. Zamo Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis Am J Pathol 162 2003 1495 1502
65. W. He, C. Dai, and Y. Li Wnt/beta-catenin signaling promotes renal interstitial fibrosis J Am Soc Nephrol 20 2009 765 776
66. E.E. Morrisey Wnt signaling and pulmonary fibrosis Am J Pathol 162 2003 1393 1397
67. K. Surendran, S.P. McCaul, and T.C. Simon A role for Wnt-4 in renal fibrosis Am J Physiol Renal Physiol 282 2002 F431 F441
68. F. Jiang, C.J. Parsons, and B. Stefanovic Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation J Hepatol 45 2006 401 409
69. S.T. Rashid, J.D. Humphries, and A. Byron Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver J Proteome Res 11 2012 4052 4064
70. W.J. Xiong, L.J. Hu, and Y.C. Jian Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays World J Gastroenterol 18 2012 1745 1752
71. C. Kordes, I. Sawitza, and D. Haussinger Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells Biochem Biophys Res Commun 367 2008 116 123
72. W.S. Ge, Y.J. Wang, and J.X. Wu Beta-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/beta-catenin signaling inhibits hepatic stellate cell activation Mol Med Rep 9 2014 2145 2151
73. J.H. Cheng, H. She, and Y.P. Han Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis Am J Physiol Gastrointest Liver Physiol 294 2008 G39 G49
74. S.J. Myung, J.H. Yoon, and G.Y. Gwak Wnt signaling enhances the activation and survival of human hepatic stellate cells FEBS Lett 581 2007 2954 2958
75. E.L. Haughton, S.J. Tucker, and C.J. Marek Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro Gastroenterology 131 2006 194 209
76. N.L. Zhu, J. Wang, and H. Tsukamoto The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells J Biol Chem 285 2010 30463 30471
77. A. Yanagida, K. Iwaisako, and E. Hatano Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells Biochim Biophys Acta 1812 2011 1403 1411
78. W. Li, C. Zhu, and Y. Li Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/beta-catenin signaling pathway Gut Liver 8 2014 282 291
79. S.E. Ross, N. Hemati, and K.A. Longo Inhibition of adipogenesis by Wnt signaling Science 289 2000 950 953
80. I.R. Wanless, S. Albrecht, and J. Bilbao Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome Mod Pathol 2 1989 456 462
81. S. Rebouissou, G. Couchy, and L. Libbrecht The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules J Hepatol 49 2008 61 71
82. J.C. Nault, P. Bioulac-Sage, and J. Zucman-Rossi Hepatocellular benign tumors-from molecular classification to personalized clinical care Gastroenterology 144 2013 888 902
83. Y.W. Chen, Y.M. Jeng, and S.H. Yeh P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia Hepatology 36 2002 927 935
84. J. Mazumdar, W.T. O'Brien, and R.S. Johnson O2 regulates stem cells through Wnt/beta-catenin signalling Nat Cell Biol 12 2010 1007 1013
85. O. Bluteau, E. Jeannot, and P. Bioulac-Sage Bi-allelic inactivation of TCF1 in hepatic adenomas Nat Genet 32 2002 312 315
86. J. Zucman-Rossi, E. Jeannot, and J.T. Nhieu Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC Hepatology 43 2006 515 524
87. S. Rebouissou, M. Amessou, and G. Couchy Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours Nature 457 2009 200 204
88. C. Pilati, E. Letouze, and J.C. Nault Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation Cancer Cell 25 2014 428 441
89. P. Bioulac-Sage, S. Rebouissou, and C. Thomas Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry Hepatology 46 2007 740 748
90. A. Tannapfel, and C. Wittekind Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis Virchows Arch 440 2002 345 352
91. J.M. Llovet, S. Ricci, and V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
92. A. Ihara, H. Koizumi, and R. Hashizume Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas Hepatology 23 1996 1441 1447
93. A. de La Coste, B. Romagnolo, and P. Billuart Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas Proc Natl Acad Sci U S A 95 1998 8847 8851
94. S. Satoh, Y. Daigo, and Y. Furukawa AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 Nat Genet 24 2000 245 250
95. K. Taniguchi, L.R. Roberts, and I.N. Aderca Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas Oncogene 21 2002 4863 4871
96. J. Zucman-Rossi, S. Benhamouche, and C. Godard Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas Oncogene 26 2007 774 780
97. P. Merle, S. de la Monte, and M. Kim Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma Gastroenterology 127 2004 1110 1122
98. S.B. Nambotin, L. Lefrancois, and X. Sainsily Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma J Hepatol 54 2011 288 299
99. M. Kim, H.C. Lee, and O. Tsedensodnom Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells J Hepatol 48 2008 780 791
100. K.C. Ban, H. Singh, and R. Krishnan GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma Cancer Lett 199 2003 201 208
101. Y.L. Shih, R.Y. Shyu, and C.B. Hsieh Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma Cancer 107 2006 579 590
102. H. Takagi, S. Sasaki, and H. Suzuki Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma J Gastroenterol 43 2008 378 389
103. G.J. Feng, W. Cotta, and X.Q. Wei Conditional disruption of Axin1 leads to development of liver tumors in mice Gastroenterology 143 2012 1650 1659
104. J.M. Lee, J. Yang, and P. Newell Beta-catenin signaling in hepatocellular cancer: implications in inflammation, fibrosis, and proliferation Cancer Lett 343 2014 90 97
105. S. Boyault, D.S. Rickman, and A. de Reynies Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52
106. P. Legoix, O. Bluteau, and J. Bayer Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity Oncogene 18 1999 4044 4046
107. H. Huang, H. Fujii, and A. Sankila Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection Am J Pathol 155 1999 1795 1801
108. H.C. Hsu, Y.M. Jeng, and T.L. Mao Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis Am J Pathol 157 2000 763 770
109. G. Amaddeo, Q. Cao, and Y. Ladeiro Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas Gut 64 2015 820 829
110. T.R. Devereux, M.C. Stern, and G.P. Flake CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1 Mol Carcinog 31 2001 68 73
111. Y. Edamoto, A. Hara, and W. Biernat Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis Int J Cancer 106 2003 334 341
112. J.C. Nault, M. Mallet, and C. Pilati High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions Nat Commun 4 2013 2218
113. K.N. Nejak-Bowen, and S.P. Monga Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad Semin Cancer Biol 21 2011 44 58
114. R.H. Yuan, Y.M. Jeng, and R.H. Hu Role of p53 and beta-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma J Gastrointest Surg 15 2011 321 329
115. J.T. Nhieu, C.A. Renard, and Y. Wei Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation Am J Pathol 155 1999 703 710
116. T. Suzuki, H. Yano, and Y. Nakashima Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process J Gastroenterol Hepatol 17 2002 994 1000
117. M. Austinat, R. Dunsch, and C. Wittekind Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma Mol Cancer 7 2008 21
118. B. Dal Bello, L. Rosa, and N. Campanini Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation Clin Cancer Res 16 2010 2157 2166
119. A.S. Lok, L.B. Seeff, and T.R. Morgan Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease Gastroenterology 136 2009 138 148
120. A. Cadoret, C. Ovejero, and S. Saadi-Kheddouci Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin Cancer Res 61 2001 3245 3249
121. N. Harada, H. Miyoshi, and N. Murai Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin Cancer Res 62 2002 1971 1977
122. K.N. Nejak-Bowen, M.D. Thompson, and S. Singh Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin Hepatology 51 2010 1603 1613
123. X. Tan, U. Apte, and A. Micsenyi Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver Gastroenterology 129 2005 285 302
124. N. Harada, H. Oshima, and M. Katoh Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations Cancer Res 64 2004 48 54
125. H. Miyoshi, A. Deguchi, and M. Nakau Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+/- mice Cancer Sci 100 2009 2046 2053
126. R. Bauer-Hofmann, F. Klimek, and A. Buchmann Role of mutations at codon 61 of the c-Ha-ras gene during diethylnitrosamine-induced hepatocarcinogenesis in C3H/He mice Mol Carcinog 6 1992 60 67
127. S. Colnot, T. Decaens, and M. Niwa-Kawakita Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas Proc Natl Acad Sci U S A 101 2004 17216 17221
128. A.P. Haramis, A. Hurlstone, and Y. van der Velden Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia EMBO Rep 7 2006 444 449
129. J. Qian, A.A. Sarnaik, and T.M. Bonney The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus Gastroenterology 135 2008 152 162
130. H. Aydinlik, T.D. Nguyen, and O. Moennikes Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors Oncogene 20 2001 7812 7816
131. H. Huang, T. Ushijima, and M. Nagao Beta-catenin mutations in liver tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in CDF1 mice Cancer Lett 198 2003 29 35
132. A. Koch, D. Denkhaus, and S. Albrecht Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene Cancer Res 59 1999 269 273
133. Y. Udatsu, T. Kusafuka, and S. Kuroda High frequency of beta-catenin mutations in hepatoblastoma Pediatr Surg Int 17 2001 508 512
134. Y. Wei, M. Fabre, and S. Branchereau Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas Oncogene 19 2000 498 504
135. Y.M. Jeng, M.Z. Wu, and T.L. Mao Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma Cancer Lett 152 2000 45 51
136. H. Kurahashi, K. Takami, and T. Oue Biallelic inactivation of the APC gene in hepatoblastoma Cancer Res 55 1995 5007 5011
137. H. Oda, Y. Imai, and Y. Nakatsuru Somatic mutations of the APC gene in sporadic hepatoblastomas Cancer Res 56 1996 3320 3323
138. S. Cairo, C. Armengol, and A. De Reynies Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer Cancer Cell 14 2008 471 484
139. R. Fukuzawa, J. Hata, and Y. Hayashi Beckwith-Wiedemann syndrome-associated hepatoblastoma: wnt signal activation occurs later in tumorigenesis in patients with 11p15.5 uniparental disomy Pediatr Dev Pathol 6 2003 299 306
140. A.G. Lade, and S.P. Monga Beta-catenin signaling in hepatic development and progenitors: which way does the WNT blow? Dev Dyn 240 2011 486 500
141. D. Shin, and S.P. Monga Cellular and molecular basis of liver development Compr Physiol 3 2013 799 815
142. D. Lopez-Terrada, P.H. Gunaratne, and A.M. Adesina Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors Hum Pathol 40 2009 783 794
143. C. Armengol, S. Cairo, and M. Fabre Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model Int J Biochem Cell Biol 43 2011 265 270
144. J. Tao, D.F. Calvisi, and S. Ranganathan Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice Gastroenterology 147 2014 690 701
145. R. Gebhardt Speeding up hepatocyte proliferation: how triiodothyronine and beta-catenin join forces Hepatology 59 2014 2074 2076
146. E.R. Delgado, J. Yang, and J. So Identification and characterization of a novel small-molecule inhibitor of beta-catenin signaling Am J Pathol 184 2014 2111 2122
147. K.H. Emami, C. Nguyen, and H. Ma A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected] Proc Natl Acad Sci U S A 101 2004 12682 12687
148. H.J. Lenz, and M. Kahn Safely targeting cancer stem cells via selective catenin coactivator antagonism Cancer Sci 105 2014 1087 1092
149. E. Delgado, H. Okabe, and M. Preziosi Complete response of Ctnnb1-mutated tumours to beta-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model J Hepatol 62 2015 380 387
150. D.F. Calvisi Molecularly targeted therapies for human hepatocellular carcinoma: should we start from beta-catenin inhibition? J Hepatol 62 2015 257 259
151. E.D. Wickline, P.K. Awuah, and J. Behari Hepatocyte gamma-catenin compensates for conditionally deleted beta-catenin at adherens junctions J Hepatol 55 2011 1256 1262
152. E.D. Wickline, Y. Du, and D.B. Stolz γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after beta-catenin knockdown Neoplasia 15 2013 421 434
153. D. Yan, M. Wiesmann, and M. Rohan Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors Proc Natl Acad Sci U S A 98 2001 14973 14978
154. S. Ranganathan, X. Tan, and S.P. Monga beta-Catenin and met deregulation in childhood hepatoblastomas Pediatr Dev Pathol 8 2005 435 447
155. J. Gotoh, M. Obata, and M. Yoshie Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis Carcinogenesis 24 2003 435 442
156. S. Sekine, P.J. Gutierrez, and B.Y. Lan Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy Hepatology 45 2007 361 368
157. X. Tan, Y. Yuan, and G. Zeng Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development Hepatology 47 2008 1667 1679
158. Y. Yamamoto, M. Sakamoto, and G. Fujii Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations Hepatology 37 2003 528 533
159. A. Cadoret, C. Ovejero, and B. Terris New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism Oncogene 21 2002 8293 8301
160. S. Loeppen, D. Schneider, and F. Gaunitz Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital Cancer Res 62 2002 5685 5688
161. T. Zhang, T. Otevrel, and Z. Gao Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer Cancer Res 61 2001 8664 8667
162. J. Roose, G. Huls, and M. van Beest Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1 Science 285 1999 1923 1926
163. H. Okabe, E. Delgado, and J.M. Lee Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma PLoS One 9 2014 e98817
164. C. Ovejero, C. Cavard, and A. Perianin Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver Hepatology 40 2004 167 176
165. E. Delgado, R. Bahal, and J. Yang β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid Curr Cancer Drug Targets 13 2013 867 878
166. X. Zhang, J.P. Gaspard, and D.C. Chung Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia Cancer Res 61 2001 6050 6054
167. K.N. Nejak-Bowen, G. Zeng, and X. Tan Beta-catenin regulates vitamin C biosynthesis and cell survival in murine liver J Biol Chem 284 2009 28115 28127
168. C.M. Wong, S.T. Fan, and I.O. Ng beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance Cancer 92 2001 136 145
169. Y. Kondo, Y. Kanai, and M. Sakamoto Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma Jpn J Cancer Res 90 1999 1301 1309